The most common co-mutations among the AML cases were DNMT3A with TET2, DNMT3A with SRSF2, TET2 with SRSF2, and IDH2 with SRSF2 54], while most of the controls only had sole driver mutations present. This evidence concerns the gene TET2 and acute myeloid leukemia.